Lupin to market Novartis' inhaler under Loftair brand name
Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India
Apr 11, 2016, 17:24 PM IST
Modi government clears FDI proposals worth Rs 1,827.24 crore
The Finance Ministry on Friday said it has cleared 12 FDI applications, including that of Ratnakar Bank to raise foreign equity limit to 74 percent, entailing total investment of Rs 1,827.24 crore.
Jan 10, 2015, 00:30 AM IST